Centro de Investigaciones Médicas Tucumán

Lavalle 506, T4000 San Miguel de Tucumán, Tucumán, Argentina

Select an option

I am a doctor

I am a sponsor

Our team

Medical staff

Victor Pastrana

Paula Corbalán

Horacio Berman

Jorge Gustavo José

Alberto Jorge Spindler

Walter Spindler

Eduardo Ezequiel Martínez

Alberto Berman

Nicolás Destefani Villafañe

Pamela Giorgis

Maria Alejandra Herrera

Maria Florencia Montesinos

Natalia Ruiz

María Julia Periillo

Analia Puparelli

Noemi Costilla

Legal and Administrative staff

Study Coordinator Lorena Diaz Cordoba

Open studies

Lupus

Phase 3 Study of Anifrolumab in Adult Patients With Active Proliferative Lupus Nephritis - IRIS - AstraZeneca

Efficacy and Safety of Frexalimab (SAR441344) in the Treatment of Systemic Lupus Erythematosus - APATURA - Sanofi

A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus Erythematosus - POETYK SLE-2 - Bristol-Myers Squibb

A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus - AMETHYST - Biogen

Phase 3 Study to Evaluate Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 2) - SIRIUS-SLE 2 - Novartis Pharmaceuticals

A Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus Erythematosus - OPUS-1 - Idorsia Pharmaceuticals Ltd.

A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus - PHOENYCS FLY - UCB Biopharma SRL

A Study to Assess the Safety, Tolerability, and Efficacy of IMVT-1402 in Participants With Cutaneous Lupus Erythematosus (CLE) - Immunovant Sciences GmbH

Rare diseases

A Study Evaluating the Efficacy and Safety of Vixarelimab in Participants With Idiopathic Pulmonary Fibrosis and in Participants With Systemic Sclerosis-Associated Interstitial Lung Disease - Moonscape - Genentech, Inc.

A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome - POETYK SjS-1 - Bristol-Myers Squibb

A Safety and Efficacy Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-Severe Symptom State - HZNP-DAZ-303 - Amgen

A Study of the Efficacy and Safety of Efgartigimod in Patients With Primary Sjögren's Syndrome - Unity - argenx

Nipocalimab in Moderate to Severe Sjogren's Disease - DAFFODIL - Janssen Research & Development, LLC

Arthritis

A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis - JUVE-X - Eli Lilly and Company

A Study of Ustekinumab or Guselkumab in Pediatric Participants With Active Juvenile Psoriatic Arthritis - PSUMMIT-Jr - Janssen Research & Development, LLC

A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced Participants With Active Psoriatic Arthritis - ICONIC-PsA 2 - Janssen Research & Development, LLC

Obesity

The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes) - TRIUMPH-OUTCOMES - Eli Lilly and Company

A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2) - SURMOUNT-ADOLESCENTS-2 - Eli Lilly and Company

Breast Cancer

A Study of DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02) - DYNASTY-Breast02 - BioNTech SE

Myasthenia gravis

Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad) - MyClad - EMD Serono Research & Development Institute, Inc.

Pulmonary fibrosis

Renal disease

The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes) - TRIUMPH-OUTCOMES - Eli Lilly and Company

Ulcerative colitis

Study to Investigate Comparative Efficacy, Safety and Immunogenicity Between AVT16 and Entyvio - Alvotech Swiss AG

Urticaria

A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria - EMBARQ-CSU1 - Celldex Therapeutics

About usOur mission Our team Partners FAQs

Medical newsLatest news Studies Interviews Testimonials

ProductsUEPM Onco UEPM Physicians

LinksDownloads